Ovulation on Clomid, Letrozole & Ovidrel Trigger Shots: Complete Timing Guide

§ Executive Summary: Medicated Ovulation Induction

When regular spontaneous ovulation is absent (anovulation), irregular (oligo-ovulation common in Polycystic Ovary Syndrome / PCOS), or when couples experience unexplained subfertility, reproductive endocrinologists and gynecologists prescribe targeted ovulation induction protocols.

The two primary oral front-line medications are Clomiphene Citrate (Clomid) and Letrozole (Femara), frequently paired with a mid-cycle human Chorionic Gonadotropin (hCG) trigger shot (Ovidrel or Pregnyl) to schedule intrauterine insemination (IUI) or timed intercourse (TIC) with exact precision.

You can calculate your medication days, follicular ultrasound monitoring dates, and 36-hour trigger clock automatically using our interactive Clomid & Letrozole Ovulation Calculator.

§ 1. Clomid vs. Letrozole: How They Stimulate Follicle Growth

While both Clomid and Letrozole accomplish the ultimate goal of stimulating the ovaries to mature one or more Graafian follicles, their underlying biochemical pharmacology differs fundamentally:

┌────────────────────────────────────────────────────────────────────────┐
│             ORAL OVULATION INDUCTION PHARMACOLOGY                     │
├──────────────────────────────────┬─────────────────────────────────────┤
│  CLOMIPHENE CITRATE (CLOMID)     │  LETROZOLE (FEMARA)                 │
├──────────────────────────────────┼─────────────────────────────────────┤
│  Drug Class: SERM                │  Drug Class: Aromatase Inhibitor    │
│  Mechanism: Blocks Hypothalamic  │  Mechanism: Inhibits Cytochrome     │
│  Estrogen Receptors (Antagonist) │  P450 Aromatase Enzyme              │
│  Systemic Estrogen: Circulates   │  Systemic Estrogen: Temporarily     │
│  freely but hypothalamus blinded │  suppressed from conversion         │
│  Endometrial Effect: May cause   │  Endometrial Effect: Leaves uterine │
│  anti-estrogenic thinning (<7mm) │  receptors intact; thicker lining   │
│  First-Line Recommendation:      │  First-Line Recommendation:         │
│  Unexplained Infertility         │  PCOS (ACOG & ASRM Gold Standard)   │
└──────────────────────────────────┴─────────────────────────────────────┘

A. Clomiphene Citrate (Clomid)

Clomid acts as a competitive antagonist at estrogen receptor sites in the hypothalamus and anterior pituitary gland. By blocking endogenous estradiol from binding to its negative feedback receptors, Clomid tricks the brain into perceiving that systemic estrogen levels are critically depleted.

In response, the pituitary releases a compensatory burst of pulsatile Gonadotropin-Releasing Hormone (GnRH), which directly stimulates increased secretion of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH). This elevated FSH overrides natural monofollicular selection, recruiting 1 to 3 follicles to develop to full pre-ovulatory maturity.

B. Letrozole (Femara)

Letrozole functions through an alternate enzymatic pathway. Rather than blocking estrogen receptors, Letrozole inhibits the cytochrome P450 aromatase enzyme, which is responsible for converting androgens into estrogens (specifically, androstenedione into estrone and testosterone into estradiol).

By temporarily decreasing estrogen biosynthesis in peripheral tissues and granulosa cells, central negative feedback is lifted, triggering a gentle, physiological release of pituitary FSH.

In landmark randomized clinical trials (Legro et al., 2014; New England Journal of Medicine), Letrozole demonstrated significantly higher cumulative ovulation rates (61.7% vs. 48.3%) and higher live-birth rates (27.5% vs. 19.1%) compared to Clomid in women with polycystic ovary syndrome (PCOS). Both the American College of Obstetricians and Gynecologists (ACOG) and the American Society for Reproductive Medicine (ASRM) currently designate Letrozole as the first-line oral agent for anovulatory infertility in PCOS.

§ 2. Protocol Schedules: Days 3–7 vs. Days 5–9

Clinicians typically prescribe oral medications for a 5-day pulse during the early follicular phase:

• Days 3 to 7 Protocol (CD3–CD7): Initiating tablets on Cycle Day 3 recruits follicles earlier in the cohort development window. This protocol is frequently favored in anovulatory cycles or younger patients, often leading to earlier ovulation (Cycle Days 13 to 16).
• Days 5 to 9 Protocol (CD5–CD9): Starting on Cycle Day 5 recruits follicles after initial physiological selection has commenced. It tends to recruit fewer codominant follicles, lowering the risk of high-order multiple gestations, with ovulation occurring slightly later (Cycle Days 15 to 19).

§ 3. Why Ovulation Tests (OPKs) Can Give False Positives on Clomid

A critical trap for patients tracking cycles at home is the timing of urinary Luteinizing Hormone (LH) test strips:

1. Pituitary LH Surges During Active Drug Administration: Clomid directly stimulates pituitary LH pulses while the medication is being metabolized.
2. False Surges Prior to Follicular Maturity: If you dip an OPK strip on Cycle Days 6, 7, or 8, the test strip will often show a strong positive line. However, your lead follicle at this stage is typically only 8 to 11 mm in diameter—far too immature to contain a viable, meiotically mature egg.
3. Clinical Protocol Summary: In standard CD3–CD7 protocols, clinicians typically instruct patients to wait until at least Cycle Day 10 before testing. Reproductive endocrinologists generally advise waiting until Cycle Day 10 for OPK testing because testing earlier while tablets are actively being cleared often reflects medication kinetics rather than authentic follicular maturation.

§ 4. The 36-Hour Trigger Shot: Ovidrel & Pregnyl Kinetics

In monitored medicated cycles, clinicians frequently do not wait for a spontaneous natural LH surge. Once transvaginal ultrasound confirms a lead follicle has reached ≥18 to 22 mm with a trilaminar endometrial lining of ≥7 mm, an hCG trigger injection is administered.

The Mechanism of Action

Because human Chorionic Gonadotropin shares an identical alpha subunit and a highly homologous beta subunit with LH, it binds directly to the LH/CG receptor on granulosa cells. Within hours of injection:

• The immature primary oocyte resumes meiosis, extruding the first polar body to become a fertilizable secondary oocyte (Metaphase II).
• Granulosa cells begin synthesizing progesterone, luteinizing the follicular wall.
• Prostaglandins and matrix metalloproteinases dissolve the outer ovarian cortical capsule.
• Follicular rupture occurs predictably between 36 and 40 hours post-injection.

§ 5. Timed Intercourse vs. IUI Scheduling

Because the trigger shot creates a deterministic 36-hour clock, timing sexual intercourse or intrauterine insemination (IUI) is optimized:

[Trigger Shot Injected: Hour 0]
       │
       ├─► Hour 12–24: First Intercourse Session (Sperm capacitate in tubes)
       │
       ├─► Hour 36: Follicular Rupture / Ovulation Occurs
       │     └─► Intrauterine Insemination (IUI) Performed at Hour 36
       │
       └─► Hour 48: Follow-up Intercourse Session (Insurance buffer)

• Timed Intercourse (TIC): Have intercourse the night of the trigger shot (12 hours later) and the morning/afternoon 36 hours later (the day of ovulation). Remember that human sperm require 5 to 10 hours of capacitation in the female reproductive tract before they are capable of penetrating the egg's zona pellucida. Having intercourse prior to ovulation ensures capacitated sperm are already waiting when the egg releases.
• Intrauterine Insemination (IUI): In IUI, washed and concentrated motile sperm are deposited directly past the cervix into the uterine fundus. Because washed sperm do not require standard cervical transit, IUI is performed precisely 36 hours (or 35–37 hours) post-trigger to coincide directly with follicle rupture.

§ 6. "Testing Out the Trigger": Avoiding False-Positive Pregnancy Tests

The most emotionally challenging aspect of an hCG trigger shot is the phenomenon of residual drug clearance.

A standard 250 mcg dose of Ovidrel introduces approximately 300 to 500 mIU/mL of exogenous beta-hCG into your maternal bloodstream. Because beta-hCG has a biological elimination half-life of 29 to 36 hours, it takes 10 to 14 full days for this exogenous hormone to metabolize down below the 10–25 mIU/mL threshold of home urine pregnancy tests.

If you test at 8 or 9 DPO (10 or 11 days post-trigger), you will almost certainly see two lines on a pregnancy test. This is a false positive caused by residual medication.

The Testing-Out Protocol

Patients who wish to monitor clearance test their urine with cheap paper dip-strips starting at 7 DPO:

1. Days 7–9 DPO: The test line gradually fades from moderate pink to very faint.
2. Days 10–11 DPO: The test line turns completely white/negative (trigger fully cleared).
3. Days 12–14 DPO: If the test line reappears and begins darkening, this confirms true endogenous embryonic hCG synthesis.

§ 7. Natural Cycles & Long-Term Tracking

Between medicated rounds or during rest months, tracking your natural cycle parameters and spontaneous ovulation dates allows your body to recalibrate. You can track your baseline fertile window and 6-cycle timeline anytime using our free ovulation tracker.